What Trump’s New Drug Pricing Deal Means for People With Obesity

Rebecca Robbins, Dani Blum and Margot Sanger-Katz / nytimes - The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

AI Summary: In a bold move to tackle the obesity crisis, the Trump administration has brokered agreements with industry giants such as Eli Lilly and Novo Nordisk to slash weight-loss drug prices. The deals, promising reductions as steep as $149 a month, have sparked both applause and debate over the future of drug pricing in America.

#trumpadministration #obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #governmentpolicy

Pfizer triumphs over Novo Nordisk with $10B bid for Metsera

6 months / endpoints / Elizabeth Cairns

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

6 months / nytimes / Francesca Regalado

White House strikes new deals to lower prices on obesity drugs for some

6 months / npr / Sydney Lupkin

Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month

6 months / nytimes / Rebecca Robbins, Margot Sanger-Katz and Dani Blum

What Trump’s New Drug Pricing Deal Means for People With Obesity

6 months / nytimes / Rebecca Robbins, Dani Blum and Margot Sanger-Katz

Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs

6 months / fiercehealthcare

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Public Health, Price Transparency, Vaccine Safety, Diagnostics and look for the RSS link.

StackHealth Time Machine

More StackHealth